Muscle triglycerides and mitochondrial function: possible mechanisms for the development of type 2 diabetes
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Introduction Obese and type 2 diabetic (T2DM) adolescents present with reduced insulin-stimulated glucose disposal and elevated intramyocellular lipids (IMCL) indicating comparable muscular insulin resistance and increased flux of free fatty acids (FFA) as in adult patients. In humans, the causal relationships between obesity and insulin resistance were examined in detail over the last years.Methods The impact of genetic factors was analyzed in young nonobese nondiabetic first-degree relatives of T2DM (REL-DM), whereas environmental factors were tested by challenging humans without genetic T2DM risk with lipid infusions or high-fat diets.Results REL-DM exhibit defects in mitochondrial oxidation and phosphorylation. Increased FFA availability results in accumulation of intramyocellular fatty acyl-CoA (FA-CoA) inducing a series of alterations: (i) inhibition of insulin signaling, (ii) reduction of insulin-(in)dependent glucose transport/phosphorylation, (iii) decreased insulin-stimulated glycogen synthesis, (iv) impaired insulin-stimulated oxidative phosphorylation (ATP synthesis), (v) accumulation of ectopic triglycerides (IMCL), (vi) reduced expression of peroxisome proliferator activated receptor gamma (PPARgamma) coactivator-1 (PGC-1) and PGC-1-controlled genes involved in mitochondrial biogenesis and oxidative phosphorylation and possibly also (vii) initiation of inflammatory processes by activation of PKC and nuclear factor-kappaB and decreased expression of matrix metalloproteinases (MMPs).Conclusions The abnormalities could lead to a vicious cycle in which mitochondrial dysfunction, elevation of intramycellular lipids, impaired lipid oxidation and insulin resistance amplify each other. This is similar to the adaptive changes to fasting, which prevent energy loss during excessive FFA availability. The sequence of events may start with mitochondrial dysfunction in genetic insulin resistance and with increased intramyocellular lipids in environmental insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These and other studies led to the proposal that insulin resistant humans have faulty muscle mitochondria and intrinsic deficiencies in oxidative metabolism that impinge on insulin signaling by diverting fatty acids away from oxidation and toward production of diacylglycerols and other toxic lipid species (Lowell and Shulman, 2005; Roden, 2005).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Roden, 2005
In the citing paper
“suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [16]
In the citing paper
“Recent studies have reported a mitochondrial defect in oxidative phosphorylation in skeletal muscle in variety of insulin resistant states.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [16]
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Obesity and the Metabolic Syndrome in Children and Adolescents
Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,459
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 1×
“The relative roles of lipid delivery and intramyocellular metabolism were studied in a similarly selected group of lean REL-DM featuring 60p lower insulin sensitivity and 80p higher IMCL in soleus muscle compared with their age- and body fat mass-matched control group”
BackgroundMitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107 · cited 1×
“The relationship between insulin resistance, intracellular lipids and mitochondrial metabolism was recently studied by combining1Hs6,62H 2 rglucose and l5nglycerol in lean insulin-resistant elderly humans”
BackgroundPatti, M. E., Butte, A. J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., Miyazaki, Y., Kohane, I., Costello, M., Saccone, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1032913100 · Cited by 1,952 · cited 1×
“28 and that expression of PGC-1 and PGC-1 controlled mitochondrial genes involved in electron transport, oxidative phosphorylation including ATP synthase is impaired in overt T2DM strengthens this hypothesis”
BackgroundRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709 · cited 1×
“Impaired glucose tolerance (IGT) upon oral glucose challenge is present in 20–25p of obese youngsters and defines the prediabetic state preceding overt diabetes, which occurs in ∼4p of obese adolescents”
BackgroundMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“This was followed by reductions in glucose oxidation by 40p after 2 h, insulin-stimulated glucose disposal by 46p and muscular glycogen synthesis by 50p starting at 3 h of lipidsheparin infusion”
MethodSelf-citationItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390 · cited 1×
“22 After 6 h of lipid infusion, the 43p reduction in whole body glucose disposal was accompanied by a three-fold increase in diacylglycerol (DAG), four-fold increase in protein kinase C (PKC) activity with recruitment of the β and δ isoforms of PKC to the cell membrane as well as a 70p decrease of I κ B- α , an inhibi…”
BackgroundDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311 · cited 1×
“17 and reduce the intramyocellular free glucose concentration suggesting that FFA primarily inhibit glucose transport”
Background
Cited by
Pathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670
“The recent studies have reported the existence of a defect in mitochondrial oxidative phosphorylation in skeletal muscle in insulin resistance states [16–20] and suggest that this mitochondrial defect contributes to the increased intramyocellar fat content.”
BackgroundTXNIP regulates peripheral glucose metabolism in humans
Parikh, H., Carlsson, E., Chutkow, W. A., Johansson, L. E., Storgaard, H., Poulsen, P., Saxena, R., Ladd, C., Schulze, P. C., Mazzini, M. J., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040158 · Cited by 495
“Although obesity is the most important risk factor for insulin resistance in the prediabetic state [5], other factors such as the toxic effects of elevated glucose (glucotoxicity) and lipids (lipotoxicity) also contribute to insulin resistance with progression of the disease [6].”
BackgroundMeex, R. C. R., Schrauwen-Hinderling, V. B., Moonen-Kornips, E., Schaart, G., Mensink, M., Phielix, E., van de Weijer, T., Sels, J.-P., Schrauwen, P., & Hesselink, M. K. C. (2010) · Diabetes · doi:10.2337/db09-1322 · Cited by 355
“The combination of increased intramyocellular lipid (IMCL) and a low oxidative capacity are key features in the development of muscular insulin resistance (1-3).”
BackgroundLipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343
“These and other studies led to the proposal that insulin resistant humans have faulty muscle mitochondria and intrinsic deficiencies in oxidative metabolism that impinge on insulin signaling by diverting fatty acids away from oxidation and toward production of diacylglycerols and other toxic lipid species (Lowell and…”
BackgroundCorrea-de-Araujo, R., Harris-Love, M. O., Miljkovic, I., Fragala, M. S., Anthony, B. W., & Manini, T. M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00087 · Cited by 268
“Impaired skeletal muscle mitochondrial function, which directs fatty acids toward storage as opposed to oxidation, may also contribute to agingrelated increases in skeletal muscle fat accumulation (Roden, 2005; Mathieu et al., 2010).”
BackgroundMitochondrial and cellular mechanisms for managing lipid excess
Aon, M. A., Bhatt, N., & Cortassa, S. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00282 · Cited by 253
“These impairments impinge on insulin signaling by diverting FAs away from oxidation and toward production of DAGs, ceramide and other toxic lipid species (Lowell and Shulman, 2005; Roden, 2005).”
BackgroundMuscle Mitochondrial ATP Synthesis and Glucose Transport/Phosphorylation in Type 2 Diabetes
Szendroedi, J., Schmid, A. I., Chmelik, M., Toth, C., Brehm, A., Krssak, M., Nowotny, P., Wolzt, M., Waldhausl, W., & Roden, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040154 · Cited by 243
“This suggests that IMCL do not directly contribute to insulin resistance but accumulate as a consequence of increased lipid availability from augmented lipolysis and excess dietary fat supply and/or of impaired mitochondrial lipid oxidation [6].”
BackgroundSelf-citationMiljkovic, I., & Zmuda, J. M. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328337d826 · Cited by 234
He, H.-J. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i5.94 · Cited by 236
“The elevation of muscle lipid content then activates protein kinase C, which blocks insulin receptor substrate-1 phosphorylation and downstream insulin signaling [29] .”
Diabetes, Sarcopenia, and Frailty
Morley, J. E. (2008) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2008.03.004 · Cited by 186
“Free fatty acid accumulation within tissue leads to abnormalities in phosphorylation of the insulin receptor substrate and function of the glucose transporter receptor [79].”
BackgroundDeterminants of intramyocellular triglyceride turnover: implications for insulin sensitivity
Moro, C., Bajpeyi, S., & Smith, S. R. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00624.2007 · Cited by 179
Peroxisome Proliferator-Activated Receptor Expression Is Reduced in Skeletal Muscle in COPD
Remels, A. H., Schrauwen, P., Broekhuizen, R., Willems, J., Kersten, S., Gosker, H. R., & Schols, A. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00144106 · Cited by 168
“Intriguingly, diabetes mellitus and congestive heart failure, diseases characterised by systemic inflammation and increased levels of inactivity, are also characterised by decreased muscular levels of PPAR and/or PGC-1a, suggesting a prominent role for inflammation and physical activity level in controlling PPAR and P…”
BackgroundCharacterization of age-related gene expression profiling in bone marrow and epididymal adipocytes
Liu, L.-F., Shen, W.-J., Ueno, M., Patel, S., & Kraemer, F. B. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-212 · Cited by 156
“A decrease in mitochondria function is associated with aging in heart, muscle, liver and white adipocytes in animals [36-39].”
BackgroundEffect of the dietary fat quality on insulin sensitivity
Galgani, J. E., Uauy, R. D., Aguirre, C. A., & Díaz, E. O. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508894408 · Cited by 154
Abdul-Ghani, M. A., Muller, F. L., Liu, Y., Chavez, A. O., Balas, B., Zuo, P., Chang, Z., Tripathy, D., Jani, R., Molina-Carrion, M., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90287.2008 · Cited by 140
“The mitochondrial defect observed following acute elevation (6 h) in plasma FFA concentration most likely results from an acquired functional defect rather than from a decrease in mitochondrial number (9, 44).”
Holmström, M. H., Iglesias-Gutierrez, E., Zierath, J. R., & Garcia-Roves, P. M. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00159.2011 · Cited by 137
“In humans, skeletal muscle insulin resistance correlates with reduced expression of genes involved in mitochondrial oxidative phosphorylation (42) and alterations in ultrastructure and reduced mitochondrial size (27, 44).”
BackgroundHepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease
Koliaki, C. C., & Roden, M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.002 · Cited by 144
“Insulin resistance is tightly associated with ectopic fat accumulation in peripheral tissues, including skeletal muscle and liver as the most important sites (Roden, 2005; Szendroedi and Roden, 2009).”
BackgroundSelf-citationLanza, I. R., Blachnio-Zabielska, A., Johnson, M. L., Schimke, J. M., Jakaitis, D. R., Lebrasseur, N. K., Jensen, M. D., Sreekumaran Nair, K., & Zabielski, P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2012 · Cited by 135
Interethnic Differences in Muscle, Liver and Abdominal Fat Partitioning in Obese Adolescents
Líška, D., Dufour, S., Zern, T. L., Taksali, S. E., Cali, A. M. G., Dziura, J. D., Shulman, G. I., Pierpont, B. M., & Caprio, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000569 · Cited by 143
Liu, J., Shen, W., Zhao, B., Wang, Y., Wertz, K., Weber, P., & Zhang, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.007 · Cited by 143
“Indeed, reduced PGC-1α expression seems to be involved in obesity and the prediabetic state in skeletal muscle [29–32].”
BackgroundDiabesity: therapeutic options
Colagiuri, S. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01182.x · Cited by 118
“Elevated free fatty acid levels, and the conversion of free fatty acids to long chain acyl CoA derivatives, results in reduced insulin signalling and glucose transport, as well as further insulin resistance in liver and muscle [62,63].”
BackgroundMitochondrial Biogenesis in Health and Disease. Molecular and Therapeutic Approaches
Sanchis-Gomar, F., Garcia-Gimenez, J., Gomez-Cabrera, M., & Pallardo, F. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140306095106 · Cited by 118
“Thus, reduced PGC-1 expression is implicated in obesity and the pre-diabetic state in skeletal muscle [150-153].”
BackgroundEctopic fat and insulin resistance
Lettner, A., & Roden, M. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0032-z · Cited by 106
Self-citationShen, W., Liu, K., Tian, C., Yang, L., Li, X., Ren, J., Packer, L., Cotman, C. W., & Liu, J. (2007) · Diabetologia · doi:10.1007/s00125-007-0852-4 · Cited by 103
“Therefore, regulating Pparg/a activity and adipocyte metabolism may improve insulin sensitivity and glucose disposal [2, 5, 8].”
Loss of Metabolic Plasticity Underlies Metformin Toxicity in Aged Caenorhabditis Elegans
Espada, L., Dakhovnik, A., Chaudhari, P., Martirosyan, A., Miek, L., Poliezhaieva, T., Schaub, Y., Nair, A., Döring, N., Rahnis, N., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00307-1 · Cited by 100
Metabolic Network Topology Reveals Transcriptional Regulatory Signatures of Type 2 Diabetes
Zelezniak, A., Pers, T. H., Soares, S., Patti, M., & Patil, K. R. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000729 · Cited by 95
“With lipid excess and/or impaired oxidation, as observed in obesity and/or inactivity, flux of long-chain acyl CoAs (LC-CoA) may be redirected into cytosolic lipid species such as diacylglycerols (DAG), triacylglycerols (TG) and ceramides (derivatives of sphingosine and fatty acid metabolism) [5] that are correlated w…”
BackgroundResultPu, J., Peng, G., Li, L., Na, H., Liu, Y., & Liu, P. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011254 · Cited by 86
Kim, H.-K., & Kim, C.-H. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1348 · Cited by 96
Maassen, J. A., Romijn, J. A., & Heine, R. J. (2007) · Diabetologia · doi:10.1007/s00125-007-0776-z · Cited by 82
“This is because the muscle switches to βoxidation to regenerate ATP when fatty acids reach a concentration sufficient to make the muscle resistant to insulin-stimulated glucose uptake [ 20 , 21].”
Lim, J. H., Lee, J. I., Suh, Y. H., Kim, W., Song, J. H., & Jung, M. H. (2006) · Diabetologia · doi:10.1007/s00125-006-0278-4 · Cited by 81
“Because it has been reported that mitochondrial dysfunction increases intramyocellular lipid metabolites, which may activate serine/threonine kinases and repress insulin signalling by phosphorylating IRS1 [12, 33–35], we probed for the presence of lipids in oligomycin-treated C2C12 cells.”
BackgroundDe Feyter, H. M., Lenaers, E., Houten, S. M., Schrauwen, P., Hesselink, M. K., Wanders, R. J. A., Nicolay, K., & Prompers, J. J. (2008) · The FASEB Journal · doi:10.1096/fj.08-112318 · Cited by 77
Lipid-mediated muscle insulin resistance: different fat, different pathways?
Ritter, O., Jelenik, T., & Roden, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1310-2 · Cited by 74
Self-citationFoods for the prevention of diabetes: how do they work?
Thomas, T., & Pfeiffer, A. F. H. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1229 · Cited by 73
“SFA-rich diets lead to an increase in intramyocellular lipid content, which is causally related to impaired insulin resistance [19,20], since specific lipid species (i.”
BackgroundMitochondrial Plasticity in Obesity and Diabetes Mellitus
Jelenik, T., & Roden, M. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4910 · Cited by 73
“1) by several mechanisms including lipotoxic and inflammatory pathways (65, 66).”
BackgroundSelf-citationEnhanced sympathetic activity in mice with brown adipose tissue transplantation (transBATation)
Zhu, Z., Spicer, E. G., Gavini, C. K., Goudjo-Ako, A. J., Novak, C. M., & Shi, H. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.11.008 · Cited by 77
Mitochondrial fitness and insulin sensitivity in humans
Szendroedi, J., & Roden, M. (2008) · Diabetologia · doi:10.1007/s00125-008-1153-2 · Cited by 71
“Hyperglycaemia and impaired inhibition of lipolysis resulting from insulin resistance induced glucolipotoxicity which initiates a vicious cycle of metabolic decompensation, especially in association with a sedentary lifestyle and high-fat diet [ 7 ].”
BackgroundSelf-citationProtective Mechanisms of Mitochondria and Heart Function in Diabetes
Aon, M. A., Tocchetti, C. G., Bhatt, N., Paolocci, N., & Cortassa, S. C. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6123 · Cited by 78
“These deficits impinge on insulin signaling by diverting FAs away from oxidation toward production of diacylglycerols, ceramide, and other toxic lipid species (126, 164).”
Mitochondrial function and endocrine diseases
Stark, R., & Roden, M. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01773.x · Cited by 75
Self-citationEckel, R. H. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005320 · Cited by 78
“…coactivator-1 and PPARg coactivator-1-controlled genes involved in mitochondrial biogenesis and oxidative phosphorylation and potentially the initiation of inflammatory processes by activation of protein kinase C and NF-kB; expression of matrix metalloproteinases (for review, see Roden, 2005).”
BackgroundMitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67
“NEFAs that skeletal muscle faces in obesity [141,142] (Fig.”
Care of elderly patients with diabetes mellitus: A focus on frailty
Chen, L., Chen, Y., Lin, M.-H., Peng, L., & Hwang, S. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.008 · Cited by 77
Docosahexaenoic Acid Protects Muscle Cells from Palmitate-Induced Atrophy
Bryner, R. W., Woodworth-Hobbs, M. E., Williamson, D. L., & Alway, S. E. (2012) · ISRN Obesity · doi:10.5402/2012/647348 · Cited by 66
“Moreover, apart from measurements of AMPK activation, the conditions of obesity [55, 56] and high-fat feeding [11, 57] are shown to increase intramyocellular lipid content.”
BackgroundHénin, G., Loumaye, A., Leclercq, I. A., & Lanthier, N. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100963 · Cited by 86
“108,109 Indeed, DAG and ceramide bodies, both products of triacylglycerol oxidation, halt the translocation of glucose transporter 4 (GLUT4) into the myocyte membrane.”
BackgroundRemodeling Lipid Metabolism and Improving Insulin Responsiveness in Human Primary Myotubes
Sparks, L. M., Moro, C., Ukropcova, B., Bajpeyi, S., Civitarese, A. E., Hulver, M. W., Thoresen, G. H., Rustan, A. C., & Smith, S. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021068 · Cited by 63
“the accumulation of intramyocellular triacylglycerols (IMTG), has been associated with skeletal muscle insulin resistance (extensively reviewed in [9,10,11,12]).”
BackgroundPujia, A., Gazzaruso, C., Ferro, Y., Mazza, E., Maurotti, S., Russo, C., Lazzaro, V., Romeo, S., & Montalcini, T. (2016) · Nutrients · doi:10.3390/nu8010002 · Cited by 63
“However, it has also been demonstrated that an unhealthy lifestyle, including HF feeding and the absence of physical activity, favors incomplete β-oxidation caused by the mismatch between β-oxidation and tricarboxylic acid cycle activity, contributing to mitochondrial damage [41,42].”
BackgroundMuscle Characteristics and Body Composition of NCAA Division I Football Players
Melvin, M. N., Smith-Ryan, A. E., Wingfield, H. L., Ryan, E. D., Trexler, E. T., & Roelofs, E. J. (2014) · Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000000651 · Cited by 61
Time course of cigarette smoke-induced changes of systemic inflammation and muscle structure
Krüger, K., Dischereit, G., Seimetz, M., Wilhelm, J., Weißmann, N., & Mooren, F. C. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00074.2015 · Cited by 62
Jelenik, T., Séquaris, G., Kaul, K., Ouwens, D. M., Phielix, E., Kotzka, J., Knebel, B., Weiß, J., Reinbeck, A. L., Janke, L., et al. (2014) · Diabetes · doi:10.2337/db13-1794 · Cited by 56
“On the other hand, insulin deficiency also decreases the suppression of lipolysis in adipose tissue and liver, thereby raising circulating triglyceride (TG) and fatty acid (FA) levels, which in turn impair insulin-stimulated glucose transport by various mechanisms summarized as lipotoxicity (6,7).”
BackgroundSelf-citationNutritional Modulation of Insulin Resistance
Weickert, M. O. (2012) · Scientifica · doi:10.6064/2012/424780 · Cited by 53
“Apart from in�uencing key en�yme activities and transcription factors on an intracellular level [89], a SFAmediated increase in intramyocellular lipid content and compositionmay also activate speci�c serine kinases, �nally leading to insulin resistance [94, 95].”
BackgroundMortensen, O. H., Olsen, H., Frandsen, L., Nielsen, P. E., Nielsen, F. C., Grunnet, N., & Quistorff, B. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181c4735c · Cited by 51
HIV protease inhibitors and obesity
Anuurad, E., Bremer, A. A., & Berglund, L. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32833dde87 · Cited by 60
Diet-induced modulation of mitochondrial activity in rat muscle
Didier, L., Yerby, B., Deacon, R., & Gao, J. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00263.2007 · Cited by 49
“Although intergroup differences in ATP synthesis do not appear to be hindered by anesthesia, in vivo measurements using a combination of (31)P saturation transfer and localized (1)H-MRS may prove particularly useful for a better understanding of muscle insulin resistance, specifically the recent notion (33) of the vic…”
BackgroundSeo, Y., Shon, M.-Y., Kong, R., Kang, O., Zhou, T., Kim, D.-Y., & Kwon, D. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.05.060 · Cited by 49
Gui, W., Zhu, W. F., Zhu, Y., Tang, S., Zheng, F., Yin, X., Lin, X., & Li, H. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00654-2 · Cited by 49
Velan, S. S., Said, N., Durst, C. R., Frisbee, S. J., Frisbee, J. C., Raylman, R. R., Thomas, M. A., Rajendran, V. M., Spencer, R. G. S., & Alway, S. E. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90367.2008 · Cited by 51
“Nevertheless, the mechanisms by which these pools develop and their potential causal relationship to deficits in glucose homeostasis are incompletely understood and represent the topic of ongoing investigation (24, 26, 30).”
BackgroundMortensen, O. H., Olsen, H., Frandsen, L., Nielsen, P. E., Nielsen, F. C., Grunnet, N., & Quistorff, B. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-s1-s38 · Cited by 54
“Although the exact mechanism is unknown, a decrease in the number of skeletal muscle mitochondria and/or in the activity of oxidative phosphorylation as well as mitochondrial dysfunction at birth may, if it is permanent, be associated with a decreased capacity for b-oxidation capacity, which may lead to increased intr…”
How Estrogens Prevent From Lipid-Induced Insulin Resistance
Jeleník, T., & Roden, M. (2013) · Endocrinology · doi:10.1210/en.2013-1112 · Cited by 51
“lipid overflow and lipotoxicity (1, 2), abnormal mitochon-”
BackgroundSelf-citationJana, B. A., Chintamaneni, P. K., Krishnamurthy, P. T., Wadhwani, A., & Mohankumar, S. K. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4551-7 · Cited by 48
Anti-diabesity middle eastern medicinal plants and their action mechanisms
Saad, B., Kmail, A., & Haq, S. Z. H. (2022) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2022/2276094 · Cited by 42
Huynh, T. V., Rethi, L., Rethi, L., Chen, C., Chen, Y., & Kao, Y. (2023) · Cells · doi:10.3390/cells12091223 · Cited by 46
Peroxisome proliferator-activated receptors: a therapeutic target in COPD?: Fig. 1—
Remels, A. H., Gosker, H. R., Schrauwen, P., Langen, R. C., & Schols, A. M. (2008) · European Respiratory Journal · doi:10.1183/09031936.00068207 · Cited by 40
Developmental Origins of Obesity: Programming of Food Intake or Physical Activity?
Gardner, D. S., & Rhodes, P. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4020-9173-5_9 · Cited by 38
“For example, a reduced overall capacity for fatty acid oxidation may pre-empt intramyocellular (ectopic) fatty acid deposition which has been implicated in the pathophysiology of Type 2 Diabetes (T2D; (Roden, 2005) .”
BackgroundDiagnostic imaging in the management of patients with metabolic syndrome
Kim, S. R., & Lerman, L. O. (2017) · Translational research · doi:10.1016/j.trsl.2017.10.009 · Cited by 42
“However, it is important to note that IMCL is not a direct marker of insulin sensitivity, but may reflect accumulation from increased lipolysis, excess dietary fat, or impaired mitochondrial lipid oxidation.(48) Several studies used positron emission tomography (PET) for assessing insulin resistance.”
López-Alvarenga, J. C., Ebbesson, S. O. E., Ebbesson, L. O. E., Tejero, M. E., Voruganti, V. S., & Comuzzie, A. G. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.010 · Cited by 39
“Relatives of individuals with DM have increased FFAs availability that contribute to mitochondrial dysfunction, which can be the initial step to develop other abnormalities such as accumulation of intramyocellular lipids, impaired lipid oxidation, and insulin resistance [10].”
Campbell-Tofte, J., Mølgaard, P., Josefsen, K. E., Abdallah, Z., Hansen, S. H., Cornett, C., Mu, H., Richter, E. A., Petersen, H. W., Nørregaard, J. C., et al. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.10.013 · Cited by 37
Malin, S. K., Liu, Z., Barrett, E. J., & WELTMAN, A. L. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9352-5 · Cited by 39
Insulin Resistance: Pathophysiology and Rationale for Treatment
Muntoni, S., & Muntoni, S. (2011) · Annals of Nutrition and Metabolism · doi:10.1159/000323395 · Cited by 42
“leading to accumulation of intramyocellular lipids [”
Reduced Basal ATP Synthetic Flux of Skeletal Muscle in Patients with Previous Acromegaly
Szendroedi, J., Zwettler, E., Schmid, A. I., Chmelik, M., Pacini, G., Kacerovsky, G., Smekal, G., Nowotny, P., Wagner, O., Schnack, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003958 · Cited by 34
“1H MRS allowed to measure IMCL in soleus and tibialis muscles [21] and HCL as described [22].”
BackgroundInfluentialSelf-citationBody Weight Regulation and Obesity: Dietary Strategies to Improve the Metabolic Profile
Munsters, M. J. M., & Saris, W. H. M. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030212-182557 · Cited by 39
Hatef, B., Bahrpeyma, F., & Tehrani, M. R. M. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-22 · Cited by 35
“Strength reduction has been associated with increase of neuropathy, HbA1c and duration of diabetes [1-9].”
A novel PPARα agonist ameliorates insulin resistance in dogs fed a high-fat diet
Tsunoda, M., Kobayashi, N., Ide, T., Utsumi, M., Nagasawa, M., & Murakami, K. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00627.2007 · Cited by 34
Poolsri, W., Phokrai, P., Suwankulanan, S., Phakdeeto, N., Phunsomboon, P., Pekthong, D., Richert, L., Pongcharoen, S., & Srisawang, P. (2018) · BioMed Research International · doi:10.1155/2018/3683026 · Cited by 31
“In particular, this suppression consequently accounts for cytosolic LCFA and fatty acyl-CoA accumulation that provide a stimulatory effect on ceramide production [75, 76].”
BackgroundJiao, K., Liu, H., Chen, J., Tian, D., Hou, J., & Kaye, A. D. (2008) · Cytokine · doi:10.1016/j.cyto.2007.12.002 · Cited by 32
“[44] reported that adaptive changes occurred in humans after increased intake of fat, including decrease of oxygenation in mitochondria, deposition of fat in internal organs, elevation of plasma FFA level, increase of adipokine secretion, reduction of adiponectin secretion and developing of insulin resistance.”
Estradiol In Vivo Induces Changes in Cardiomyocytes Size in Obese Rats
Obradovic, M. M., Sudar-Milovanovic, E. M., Zafirovic, S. S., Stanimirović, J., Labudović‐Borović, M., & Isenović, E. R. (2013) · Angiology · doi:10.1177/0003319713514477 · Cited by 30
Srikanthan, P., Singhal, A., Lee, C. C., Nagarajan, R., Wilson, N. E., Roberts, C. K., Hahn, T. J., & Thomas, M. A. (2012) · Magnetic Resonance Insights · doi:10.4137/mri.s10489 · Cited by 32
Targeting the Metabolic Paradigms in Cancer and Diabetes
Bosso, M., Haddad, D., Madhoun, A. S. A., & Al‐Mulla, F. (2024) · Biomedicines · doi:10.3390/biomedicines12010211 · Cited by 30
“However, they suggested that the vicious cycle of metabolic changes in T2D starts with the increased availability of free fatty acids (FFAs), lipid accumulation in myocytes, and impaired lipid oxidation, which may cause mitochondrial dysfunction in the future [221].”
BackgroundBastien, M., Poirier, P., Brassard, P., Arsenault, B. J., Bertrand, O. F., Després, J., Costerousse, O., & Piché, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2018 · Cited by 28
Ghosh, S. K., Banerjee, K. K., Vaidya, V. A., & Kolthur‐Seetharam, U. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12397 · Cited by 25
Alipoor, B., Nikooei, S., Rezaeinejad, F., Malakooti-Dehkordi, S.-N., Sabati, Z., & Ghasemi, H. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01559-8 · Cited by 27
XIE, Y.-H., Zhang, N., Li, L., Qin-zeng, Z., Xie, L., Jiang, H., Li, L., HAO, N., & ZHANG, J.-X. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2391 · Cited by 22
“The production of reactive oxygen species by mitochondria leads to the formation of lipid peroxidation products and, in turn, can induce oxidative stress, thereby causing cellular and mitochondrial damage (57,58).”
BackgroundRETRACTED: Mitochondrial pathophysiology and type 2 diabetes mellitus
García-Rovés, P. M. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.584538 · Cited by 27
RetractedMaassen, J. A., Hart, L. M. ‘., & Ouwens, D. M. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e3282f0b774 · Cited by 22
Rashad, H. M., Metwally, F. M., Ezzat, S. M., Salama, M. M., Hashish, A. F., & Motaal, A. A. A. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1354388 · Cited by 27
“This effect is due to interference with insulin secretion and signaling that can lead to ectopic lipid accumulation and disorders in metabolism (Roden 2005).”
BackgroundBrands, M., Hoeks, J., Sauerwein, H. P., Ackermans, M. T., Ouwens, M., Lammers, N. M., van der Plas, M. N., Schrauwen, P., Groen, A. K., & Serlie, M. J. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.006 · Cited by 19
“It has been hypothesized that increased lipid availability could reducemitochondrial oxidative capacity and exacerbate lipid storage in skeletal muscle, leading to lipotoxicity and insulin resistance [9].”
BackgroundLong-term outcomes and potential mechanisms of offspring exposed to intrauterine hyperglycemia
Yan, Y., Feng, C., Yu, D., Tian, S., Zhou, Y. X., Huang, Y.-T., Cai, Y., Chen, J., Zhu, M., & Jin, M. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1067282 · Cited by 25
Nunes, P. M., van de Weijer, T., Veltien, A. A., Arnts, H., Hesselink, M. K. C., Glatz, J. F. C., Schrauwen, P., Tack, C. J., & Heerschap, A. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00597.2011 · Cited by 20
Epigenetic Manifestation of Metabolic Syndrome and Dietary Management
Chaudhary, N., Nakka, K. K., Maulik, N., & Chattopadhyay, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4387 · Cited by 22
“Proliferator-activated receptor gamma (PPAR c ) is a nuclear hormone receptor that targets many genes involved in inflammatory processes and insulin sensitivity (160, 267, 281, 310).”
Genomic and transcriptomic predictors of triglyceride response to regular exercise
Sarzynski, M. A., Davidsen, P. K., Sung, Y. J., Hesselink, M. K. C., Schrauwen, P., Rice, T., Rao, D. C., Falciani, F., & Bouchard, C. (2015) · British Journal of Sports Medicine · doi:10.1136/bjsports-2015-095179 · Cited by 21
Yerby, B., Deacon, R. W., Beaulieu, V., Liang, J., Gao, J., & Laurent, D. (2008) · Metabolism · doi:10.1016/j.metabol.2008.06.015 · Cited by 18
“Because mitochondrial ATP production is coupled to substrate utilization via a stoichiometric relationship [21], reduced ATP synthesis rates, as observed in the DIO rat model, are likely indicative of diminished mitochondrial activity [22].”
BackgroundThe Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 19
From birth to adolescence: Vienna 2005 European Childhood Obesity Group International Workshop
Pietrobelli, A., Flodmark, C., Lissau, I., Moreno, L. A., & Widhalm, K. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803080 · Cited by 15
Insulin Actions In Vivo : Glucose Metabolism
Ferrannini, E., & DeFronzo, R. A. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0305 · Cited by 17
Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type 2 Diabetes
Schön, M., Zaharia, O., Straßburger, K., Kupriyanova, Y., Bódis, K. B., Heilmann, G., Strom, A., Bönhof, G. J., MICHELOTTI, F. C., Yurchenko, I., et al. (2023) · Diabetes · doi:10.2337/db23-0353 · Cited by 18
“Higher IMCL tightly relates to lower levels of whole-body insulin sensitivity and physical fitness in sedentary humans (22), whereas a more complex tridirectional relationship has been proposed for exercise-trained people, by which higher IMCL relates to higher insulin sensitivity (12,44).”
BackgroundMethodSelf-citationKim, J., Kim, M. H., Choi, Y. Y., Hong, J., & Yang, W. M. (2016) · Journal of Natural Medicines · doi:10.1007/s11418-016-0971-7 · Cited by 14
Kim, H., Lee, S., Jeong, C., Han, Y., & Lee, M. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13432 · Cited by 15
“14 These observations suggest that the activity of mitochondria in oxidative fi bres is critical for reducing intramuscular lipids and improving muscle quality in conditions of myosteatosis.”
BackgroundAtiénzar, P. A., Abizanda, P., Guppy, A., & Sinclair, A. J. (2012) · The British Journal of Diabetes · doi:10.1177/1474651412445619 · Cited by 15
Vega, G. L., Grundy, S. M., Barlow, C. E., Leonard, D. S., Willis, B. L., DeFina, L. F., & Farrell, S. W. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.09.008 · Cited by 13
Kim, J., Kim, D., Kim, J. K., & Hwang, J. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.09.029 · Cited by 12
Lipidomic analysis of skeletal muscle tissues of p53 knockout mice by nUPLC-ESI-MS/MS
Park, S. M., Byeon, S. K., Lee, H., Sung, H., Kim, I. Y., Seong, J. K., & Moon, M. H. (2017) · Scientific Reports · doi:10.1038/s41598-017-02065-9 · Cited by 11
Hatef, B., Ghanjal, A., Meftahi, G. H., & Ashtiani, A. A. (2015) · Global Journal of Health Science · doi:10.5539/gjhs.v8n8p210 · Cited by 10
“…glycated hemoglobin A1c (HbA1c) and duration of diabetes (Andersen, 1998; Andersen, Nielsen, Mogensen, & Jakobsen, 2004; Andersen, Poulsen, Mogensen, & Jakobsen, 1996; Bokan, 2011; Halvatsiotis, Short, Bigelow, & Nair, 2002; IJzerman, 2012; Park et al., 2006; Roden, 2005; Sayer et al., 2005).”
Metadata
- Authors
- Roden, M.
- Affiliations
- Hanusch Hospital (AT)
- Corresponding author
- Roden, M
- ORCID
- Roden, M
- Venue
- International Journal of Obesity
- Published
- 2005-09
- Volume
- 29
- Issue
- S2
- Pages
- S111-S115
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W1999266780
- Cited by
- 149
- References
- 34
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 5 · 2022: 1 · 2021: 5 · 2020: 6 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 8 · 2014: 12 · 2013: 11 · 2012: 12
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, muscle triglycerides, intramyocellular lipid, mitochondrial dysfunction, insulin resistance, free fatty acids, fatty acyl-CoA, insulin signaling, glucose transport, glycogen synthesis, oxidative phosphorylation, PGC-1, mitochondrial biogenesis, obesity, adolescents, first-degree relatives of diabetics, high-fat diet, lipid infusion, inflammation, matrix metalloproteinases, nuclear factor-kappaB, protein kinase C
- MeSH terms
- Adolescent, Adult, Blood Glucose, Diabetes Mellitus, Type 2, Dietary Fats, Humans, Insulin Resistance, Lipids, Mitochondria, Muscle, Triglycerides, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.